Prudential Financial
HBIO icon

Prudential Financial’s Harvard Bioscience HBIO Stock Holding History

Prudential Financial’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,146
Closed -$175K – 2741
2024
Q2 		$175K Sell
6,146
-1,140
-16% -$40K ﹤0.01% 2496
2024
Q1 		$309K Sell
7,286
-1,670
-19% -$75.1K ﹤0.01% 2329
2023
Q4 		$479K Sell
8,956
-400
-4% -$18.1K ﹤0.01% 2148
2023
Q3 		$402K Buy
9,356
+7,810
+505% +$360K ﹤0.01% 2160
2023
Q2 		$84.9K Buy
+1,546
New +$84.8K ﹤0.01% 2491
2022
Q3 		– Sell
-1,020
Closed -$37K – 2677
2022
Q2 		$37K Buy
+1,020
New +$46K ﹤0.01% 2587
2021
Q4 		– Sell
-1,314
Closed -$92K – 2659
2021
Q3 		$92K Sell
1,314
-37
-3% -$2.94K ﹤0.01% 2535
2021
Q2 		$113K Buy
+1,351
New +$95.6K ﹤0.01% 2492

Other funds holding HBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Prudential Financial's HBIO Position: Q3 2024 in Review

Prudential Financial sold out of Harvard Bioscience (HBIO) in Q3 2024, closing a stake of 6,146 shares — an estimated $175K sold.

Prudential Financial first reported a position in HBIO in Q2 2021 and held it in 8 quarters. The position peaked at $479K in Q4 2023. 94 funds tracked by Wall St. Rank hold HBIO as of Q3 2024.

  • Prudential Financial reported no remaining Harvard Bioscience position as of Q3 2024 after selling out during the quarter.
  • Prudential Financial sold 6,146 Harvard Bioscience shares in Q3 2024, an estimated $175K.
  • Prudential Financial first reported a position in Harvard Bioscience in Q2 2021 and held it in 8 quarters.
  • Prudential Financial's Harvard Bioscience position peaked at $479K in Q4 2023.
  • 94 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2024.

Based on Prudential Financial's 13F filing for Q3 2024, filed 14 Nov 2024.